Rudra Investment Stock Tips Expert report says Pharma firm Elenbik Pharma shares a good growth in Monday's turnover. During the business, the upper circuit was introduced in the stock and the stock rose by 20 percent to Rs 521.80. The company's anti-depression drug has been approved by the US Pharma Regulator USFUA. After that, the centrally on the stock became positive and the stock gained momentum.
Anti-Depression Medicine Approved
In the US, the Health Regulator USFDA has approved the Ablobitated New Drug Application (ANDA) Bupropion Tablets of Elnbek Pharma. Tablets will be available in 75 mg and 100 mg. This drug will be used for Major Depressive Disorder. This information was given by Elenbik Pharma through press releases.
According to the Stock Tips Expert report says, by the end of December 2017, the market size of this drug was $ 3.7 million. The company also informed that its 72-approved new drug application has been approved by USFDA. It has 64 apportions final and 6 have got tentative approval.
Move on such a stock
The stock of Elenbik Pharma closed at Rs 434.85 per share on Friday. On the other hand, on Monday it opened at a price of Rs 440 per share. During the business, the price of 440 rupees was only for the stock, while, with 20 percent increase, the shares reached a price of Rs 521.80. Talking about the past year, there was a 17 percent decline in the stock till Friday. The stock was at a price of Rs 421.80 a year ago, which was on Friday at Rs 434.85.
Anti-Depression Medicine Approved
In the US, the Health Regulator USFDA has approved the Ablobitated New Drug Application (ANDA) Bupropion Tablets of Elnbek Pharma. Tablets will be available in 75 mg and 100 mg. This drug will be used for Major Depressive Disorder. This information was given by Elenbik Pharma through press releases.
According to the Stock Tips Expert report says, by the end of December 2017, the market size of this drug was $ 3.7 million. The company also informed that its 72-approved new drug application has been approved by USFDA. It has 64 apportions final and 6 have got tentative approval.
Move on such a stock
The stock of Elenbik Pharma closed at Rs 434.85 per share on Friday. On the other hand, on Monday it opened at a price of Rs 440 per share. During the business, the price of 440 rupees was only for the stock, while, with 20 percent increase, the shares reached a price of Rs 521.80. Talking about the past year, there was a 17 percent decline in the stock till Friday. The stock was at a price of Rs 421.80 a year ago, which was on Friday at Rs 434.85.
No comments:
Post a Comment